Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
about
Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of 100 StudiesType 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies.A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational studyPlatelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveAge- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA StudyImpaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice.Modeling Inpatient Glucose Management Programs on Hospital Infection Control Programs: An Infrastructural Model of ExcellenceHyperglycaemia and cardiovascular disease.Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease.Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial.Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose.Assessment of serum levels of soluble CD40L in Egyptian children and adolescents with type 1 diabetes mellitus: Relationship to microalbuminuria and glycemic control.Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins.Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!Should strict normoglycaemia be maintained in critically ill children?Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia.Diabetes mellitus after kidney transplantation: role of the impaired fasting glucose in the outcome of kidney transplantation.Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention.Etiology of Noise-Induced Hearing Loss (NIHL) and its Symptomatic Correlation with Audiometry Observations in Type II Diabetes.Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty.Insulin, glucose control and multiple organ dysfunction syndromePrognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts
P2860
Q26774723-D50A9A32-28E0-47B7-97EE-4BA1F0C70819Q34620430-20AD6546-7502-4B37-938E-BD2C740B35C7Q35072984-5D1CD1EB-1881-4C1C-B6AB-A4DAC2E2B4C6Q35073928-1A945FC7-293A-4310-9CE7-35C1679CFA83Q35174193-D7EAE185-9C16-45C9-8398-6DB26E603E4AQ36317004-528F44BB-4AEF-4EDD-A8EA-A584DFAE4A7AQ36320560-0CA714DA-316F-4EAD-BFAC-2DDF7C94B6DDQ36621669-1668E9B6-2DF2-4E12-AE69-58B4AF277EB8Q36693950-51AFE874-5641-4656-98C6-5564B0E4766DQ36889151-2682E47B-0BE6-4B73-AB7B-D8050084897CQ37117839-8F575276-56FF-41E8-8715-80536F1C15A0Q37166225-446CEE36-30AA-4082-B332-0CD8B5241522Q37197718-287FF215-DABF-4898-9038-91620DB3FC3BQ37201691-1FFD8F83-F388-479F-98C5-81A9C49948BDQ37413941-6ACAE3C4-7B18-42E6-85AD-15E0DA955458Q37472064-4BD34556-5D6E-463C-85BE-D34D9735A51EQ38187004-09EDED26-7DA3-48F8-904C-C676CCB7DCFBQ38303079-6190C96C-DC3E-4CF9-8448-94ECDC01AD8DQ39885755-7470828F-BFA6-4194-AD61-939FA5796D38Q41886708-C10E58BE-1341-4030-ADD6-29A9A472CB50Q42361908-FE427D6A-1670-4BA0-A2DD-C2B4D6CC6BE9Q42652084-EA748C7E-610A-4FBD-9CB7-A8998B409416Q43045641-4308DDD6-49D0-4B4E-B45D-D6A9643B0156Q45155420-84C6B5E4-23C4-4C8A-A197-31B7B749FA0BQ45933717-16ADD2BA-7B88-4E6D-A0F3-DC6FF583E280Q49866349-BA3BEFF4-EC3E-4A8E-8E71-CBDD6DACAED0Q51496269-0A7FF9C2-AB21-40F0-B1EB-0DCFFEF1D163Q57245133-60FCD53A-AEDD-4129-8E90-9D1707FB594FQ57821404-B30E76AA-1002-4C1C-91F7-2B56D6F2EF31
P2860
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of fasting glucose leve ...... taneous coronary intervention.
@en
Effect of fasting glucose leve ...... taneous coronary intervention.
@nl
type
label
Effect of fasting glucose leve ...... taneous coronary intervention.
@en
Effect of fasting glucose leve ...... taneous coronary intervention.
@nl
prefLabel
Effect of fasting glucose leve ...... taneous coronary intervention.
@en
Effect of fasting glucose leve ...... taneous coronary intervention.
@nl
P2093
P1476
Effect of fasting glucose leve ...... taneous coronary intervention.
@en
P2093
Benjamin D Horne
Chloe A Allen Maycock
Farangis Lavasani
Intermountain Heart Collaborative Study Group
Jeffrey L Anderson
John F Carlquist
Joseph B Muhlestein
Robert R Pearson
Tami L Bair
P304
P356
10.1016/S0002-8703(03)00235-7
P407
P577
2003-08-01T00:00:00Z